Bullish Case: Rolled-off ~43% annual decline has compressed ROL to ~$32.67, yet the business retains 99 quarters of revenue growth, recurring pest-control cash flow, and ~25x forward earnings. Calls still outbid puts on a 5:1 volume basis at active strikes, and the Nov 35C/37.5C open interest shows dip buyers positioning for an earnings-driven relief rally. Term structure drops to a 14.2% January trough—mean reversion toward $35–37.5 is the market's median path.

Bearish Case: Put volume just ran 15x call volume with the 27.5P (delta -0.10) as top trade—a classic protective signal ahead of Oct 21 earnings. Helium's AI forecast is -1.98% with a 0.1 (near-zero) correlation. Deep-OTM put IVs (22.5P at 139%) confirm the market pays richly for downside tails; backwardated term structure means near-term IV exceeds longer-dated, signaling event anxiety. 15.4x P/B leaves further multiple-compression room if Q3 misses.

Potential Outcomes:

1. 30%: Q3 beat/inline, relief to $35–38 by Dec—falsified if close stays <$33 by Thanksgiving.
2. 25%: Miss guides lower; slide to $28–30; put-wing IV spikes confirm (Helium PDF shows heavy mass at $30–32.5).
3. 20%: Range $31–34 as IV trough persists—falsified by sustained close outside band.
4. 15%: Macro/rotation shock; $27–30; SPY skew widening would corroborate.
5. 10%: Buyback/catalyst; >$40; requires call IV compression and volume surge.

October 20, 2026